Atlas Trials

A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)

Clinical trial NCT01090765 · COMPLETED

Trial details

NCT number
NCT01090765
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate CancerMetastatic Castrate Resistant Prostate Cancer
Start date
2010-02-23
Primary completion
2014-04-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.